Medicine & Life Sciences
Anti-Bacterial Agents
100%
Carbapenems
91%
Antimicrobial Stewardship
90%
Infections
66%
Bacteremia
63%
Carbapenem-Resistant Enterobacteriaceae
54%
Child
43%
cefiderocol
42%
Lactams
39%
Pediatrics
30%
carbapenemase
30%
Vancomycin
28%
Communicable Diseases
26%
Enterobacteriaceae Infections
26%
Therapeutics
25%
Pseudomonas aeruginosa
24%
Enterobacteriaceae
24%
Duration of Therapy
21%
Klebsiella pneumoniae
20%
ceftazidime drug combination avibactam
20%
Clostridium Infections
19%
Ceftriaxone
19%
Propensity Score
17%
Tazobactam Drug Combination Piperacillin
17%
Microbial Sensitivity Tests
16%
Phage Therapy
16%
beta-Lactamases
16%
Cefepime
15%
tazobactam drug combination ceftolozane
14%
Sulfamethoxazole Drug Combination Trimethoprim
14%
Methicillin-Resistant Staphylococcus aureus
13%
Retrospective Studies
12%
Mortality
12%
Plasmids
12%
Whole Genome Sequencing
12%
Genes
12%
Confidence Intervals
12%
Cohort Studies
12%
Acinetobacter baumannii
11%
Colistin
11%
Safety
11%
Observational Studies
10%
Intensive Care Units
10%
Microbial Drug Resistance
10%
Bacillus
10%
Pyelonephritis
9%
Decision Trees
9%
Epidemiology
9%